Rhythm Biosciences Limited
ASX:RHY.AX
0.1 (AUD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2018 Q4 | 2018 Q3 | 2018 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2.421 | 1.69 | 0.375 | 2.721 | 5.448 | 2.427 | 0 | 1.109 | 0 | 0.1 | 0 | 0 | 0.744 | 0 | 0.284 | 0 | 0 | 0 |
| Cost of Revenue
| 1.211 | 0.103 | 0.096 | 0.093 | 0.049 | 0.052 | 0.067 | 0.079 | 0 | 0.073 | 0 | 0.069 | 0.037 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 1.211 | 1.588 | 0.279 | 2.628 | 5.398 | 2.375 | -0.067 | 1.029 | 0 | 0.027 | 0 | -0.069 | 0.706 | 0 | 0.284 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.5 | 0.939 | 0.743 | 0.966 | 0.991 | 0.979 | 0 | 0.928 | 0 | 0.275 | 0 | 0 | 0.95 | 0 | 1 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 1.135 | 1.211 | 1.427 | 2.22 | 2.435 | 2.724 | 3.216 | 1.339 | 0.485 | 1.106 | 0.485 | 0.834 | 0.532 | 0.245 | 0.448 | 0.35 | 0.09 | 0.009 |
| General & Administrative Expenses
| 0.544 | 0.675 | 0.462 | 0.531 | 0.337 | 0.445 | 0.369 | 0.362 | 0.499 | 0.237 | 0.499 | 0.313 | 0.256 | 0.569 | 0.267 | 0.093 | 0.281 | 0.228 |
| Selling & Marketing Expenses
| 0.045 | 0.07 | 0.086 | 0.089 | 0.494 | 0.068 | 0.059 | 0.004 | 0.01 | 0.004 | 0.01 | 0.038 | 0.057 | 0.076 | 0.246 | 0.063 | 0.023 | 0.031 |
| SG&A
| 1.545 | 1.459 | 3.509 | 4.195 | 2.107 | 3.878 | 1.317 | 1.715 | 0.51 | 1.04 | 0.51 | 1.041 | 1.306 | 0.645 | 1.363 | 0.753 | 0.305 | 0.485 |
| Other Expenses
| 0 | -3.048 | 0 | 0 | 0 | 0 | 0 | 0 | -0.984 | -0.984 | -0.984 | -0.984 | -0.868 | -0.868 | -0.868 | -0.39 | -0.39 | -0.39 |
| Operating Expenses
| 2.68 | 5.717 | 4.936 | 6.416 | 4.542 | 6.602 | 4.534 | 3.053 | 0.01 | 2.146 | 0.01 | 1.874 | 1.838 | 0.022 | 1.84 | 1.134 | 0.005 | 0.684 |
| Operating Income
| -3.891 | -5.82 | -5.033 | -6.509 | -4.592 | -6.654 | -4.601 | -3.133 | -1.004 | -2.218 | -1.004 | -1.943 | -1.875 | -0.637 | -1.556 | -1.134 | -0.438 | -0.494 |
| Operating Income Ratio
| -1.607 | -3.443 | -13.424 | -2.392 | -0.843 | -2.741 | 0 | -2.826 | 0 | -22.184 | 0 | 0 | -2.521 | 0 | -5.482 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.126 | 0.038 | 0.12 | 0.124 | 0.019 | 0.021 | 0.003 | 0.01 | -0.002 | 0.113 | -0.002 | 0.026 | 0.06 | 0 | 0.081 | 0.062 | 0 | -0.187 |
| Income Before Tax
| -2.765 | -5.782 | -4.913 | -6.385 | -4.573 | -6.633 | -4.598 | -3.122 | -1.006 | -2.106 | -1.006 | -1.917 | -1.816 | -0.637 | -1.474 | -1.072 | -0.438 | -0.681 |
| Income Before Tax Ratio
| -1.142 | -3.421 | -13.104 | -2.347 | -0.839 | -2.733 | 0 | -2.817 | 0 | -21.058 | 0 | 0 | -2.441 | 0 | -5.195 | 0 | 0 | 0 |
| Income Tax Expense
| -0 | -1.69 | -0.375 | -2.706 | -0 | -2.412 | -0 | -1.109 | 0.002 | 0.002 | 0.002 | 0.002 | -0.744 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -2.765 | -4.091 | -4.538 | -3.679 | -4.573 | -4.221 | -4.598 | -2.014 | -1.008 | -2.106 | -1.008 | -1.917 | -1.072 | -0.637 | -1.474 | -1.072 | -0.438 | -0.681 |
| Net Income Ratio
| -1.142 | -2.421 | -12.105 | -1.352 | -0.839 | -1.739 | 0 | -1.817 | 0 | -21.058 | 0 | 0 | -1.441 | 0 | -5.195 | 0 | 0 | 0 |
| EPS
| -0.012 | -0.018 | -0.02 | -0.017 | -0.021 | -0.02 | -0.022 | -0.012 | -0.009 | -0.018 | -0.009 | -0.016 | -0.009 | -0.006 | -0.015 | -0.011 | -0.005 | -0.012 |
| EPS Diluted
| -0.012 | -0.018 | -0.02 | -0.017 | -0.021 | -0.02 | -0.022 | -0.012 | -0.009 | -0.018 | -0.009 | -0.016 | -0.009 | -0.006 | -0.015 | -0.011 | -0.005 | -0.012 |
| EBITDA
| -2.769 | -5.717 | -4.936 | -6.416 | -4.542 | -6.602 | -4.534 | -3.053 | -0.968 | -2.146 | -0.968 | -1.874 | -1.838 | -0.62 | -1.528 | -1.103 | -0.43 | -0.494 |
| EBITDA Ratio
| -1.144 | -3.383 | -13.167 | -2.358 | -0.834 | -2.72 | 0 | -2.754 | 0 | -21.459 | 0 | 0 | -2.471 | 0 | -5.384 | 0 | 0 | 0 |